{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T16:10:14Z","timestamp":1662135014021},"reference-count":32,"publisher":"Japanese Circulation Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2021,2,25]]},"DOI":"10.1253\/circj.cj-20-0940","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:09:29Z","timestamp":1612822169000},"page":"291-299","source":"Crossref","is-referenced-by-count":2,"title":["Novel Implantable Cardioverter Defibrillator Programming With High Rate Cut-Off, Long Detection Intervals and Multiple Anti-Tachycardia Pacing Reduces Mortality"],"prefix":"10.1253","volume":"85","author":[{"given":"Alexander Daniel","family":"Schober","sequence":"first","affiliation":[{"name":"Department of Internal Medicine 2, University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas Leonhard","family":"Schober","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 2, University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Hubauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 2, University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Fredersdorf","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 2, University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Seegers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 2, Hospital Landshut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Keyser","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Stadler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 2, University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Birner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, St. Marien Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Maier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 2, University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Jungbauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 2, University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekrem","family":"\u00dccer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 2, University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. <i>N Engl J Med<\/i> 1996; 335: 1933\u20131940.","DOI":"10.1056\/NEJM199612263352601"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. <i>N Engl J Med<\/i> 2002; 346: 877\u2013883.","DOI":"10.1056\/NEJMoa013474"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. <i>N Engl J Med<\/i> 2005; 352: 225\u2013237.","DOI":"10.1056\/NEJMoa043399"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kaas DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. <i>N Engl J Med<\/i> 2004; 350: 2140\u20132150.","DOI":"10.1056\/NEJMoa032423"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. <i>N Engl J Med<\/i> 1997; 337: 1576\u20131583.","DOI":"10.1056\/NEJM199711273372202"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. <i>Circulation<\/i> 2000; 101: 1297\u20131302.","DOI":"10.1161\/01.CIR.101.11.1297"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kuck KH, Cappato R, Siebels J, R\u00fcppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). <i>Circulation<\/i> 2000; 102: 748\u2013754.","DOI":"10.1161\/01.CIR.102.7.748"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wilkoff BL, Hess M, Young J, Abraham WT. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. <i>J Cardiovasc Electrophysiol<\/i> 2004; 15: 1002\u20131009.","DOI":"10.1046\/j.1540-8167.2004.03625.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: The ALTITUDE survival study. <i>Circulation<\/i> 2010; 122: 2359\u20132367.","DOI":"10.1161\/CIRCULATIONAHA.110.960633"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. <i>N Engl J Med<\/i> 2008; 359: 1009\u20131017.","DOI":"10.1056\/NEJMoa071098"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. <i>Heart Rhythm<\/i> 2010; 7: 353\u2013360.","DOI":"10.1016\/j.hrthm.2009.11.027"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. <i>N Engl J Med<\/i> 2012; 367: 2275\u20132283.","DOI":"10.1056\/NEJMoa1211107"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR, Heidenreich PW, et al. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. <i>J Am Coll Cardiol<\/i> 2013; 62: 1674\u20131679.","DOI":"10.1016\/j.jacc.2013.04.083"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JBM, et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: The ADVANCE III randomized clinical trial. <i>JAMA<\/i> 2013; 309: 1903\u20131911.","DOI":"10.1001\/jama.2013.4598"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, et al. Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: Results from the PROVIDE study. <i>J Cardiovasc Electrophysiol<\/i> 2014; 25: 52\u201359.","DOI":"10.1111\/jce.12273"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. <i>J Am Coll Cardiol<\/i> 2008; 52: 541\u2013550.","DOI":"10.1016\/j.jacc.2008.05.011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: Results from the prospective randomized multicenter EMPIRIC trial. <i>J Am Coll Cardiol<\/i> 2006; 48: 330\u2013339.","DOI":"10.1016\/j.jacc.2006.03.037"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kloppe A, Proclemer A, Arenal A, Lunati M, Ferrer JBM, Hersi A, et al. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: Data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial. <i>Circulation<\/i> 2014; 130: 308\u2013314.","DOI":"10.1161\/CIRCULATIONAHA.114.009468"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hayashi Y, Takagi M, Kakihara J, Sakamoto S, Doi A, Sugioka K, et al. Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients. <i>Heart Vessels<\/i> 2017; 32: 175\u2013185.","DOI":"10.1007\/s00380-016-0850-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. De Maria E, Giacopelli D, Borghi A, Modonesi L, Cappelli S. Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review. <i>World J Cardiol<\/i> 2017; 9: 429\u2013436.","DOI":"10.4330\/wjc.v9.i5.429"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, et al. 2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. <i>Europace<\/i> 2016; 18: 159\u2013183.","DOI":"10.1093\/europace\/euv411"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. <i>Circulation<\/i> 2001; 104: 796\u2013801.","DOI":"10.1161\/hc3101.093906"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkinson WO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. <i>Circulation<\/i> 2004; 110: 2591\u20132596.","DOI":"10.1161\/01.CIR.0000145610.64014.E4"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: The RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. <i>Eur Heart J<\/i> 2009; 30: 2758\u20132767.","DOI":"10.1093\/eurheartj\/ehp247"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Guerra F, Palmisano P, Dell\u2019Era G, Ziacchi M, Ammendola E, Bonelli P, et al. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD). <i>Heart Rhythm<\/i> 2016; 13: 1987\u20131992.","DOI":"10.1016\/j.hrthm.2016.06.007"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: A systematic review and meta-analysis. <i>Circ Arrhythm Electrophysiol<\/i> 2014; 7: 164\u2013170.","DOI":"10.1161\/CIRCEP.113.001217"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. <i>N Engl J Med<\/i> 1991; 325: 293\u2013302.","DOI":"10.1056\/NEJM199108013250501"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. <i>N Engl J Med<\/i> 1999; 341: 709\u2013717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. <i>N Engl J Med<\/i> 2001; 345: 1667\u20131675.","DOI":"10.1056\/NEJMoa010713"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Packer M, Coats AJ, Fowler MB, Catus HA Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. <i>N Engl J Med<\/i> 2001; 344: 1651\u20131658.","DOI":"10.1056\/NEJM200105313442201"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. <i>N Engl J Med<\/i> 2001; 345: 1435\u20131443.","DOI":"10.1056\/NEJMoa012175"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. <i>N Engl J Med<\/i> 2014; 371: 993\u20131004.","DOI":"10.1056\/NEJMoa1409077"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/3\/85_CJ-20-0940\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T03:24:41Z","timestamp":1614396281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/3\/85_CJ-20-0940\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-20-0940","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]}}}